Study Reveals Gaps in Oncology Guideline Adherence Across Tertiary Cancer Centers
Researchers examined adherence to oncology patient care guidelines in major tertiary cancer centers. They compared national standards from ICMR and NCI-India with international ones from ASCO, ESMO, and NCCN. The analysis focused on how closely doctors followed these guidelines. It also measured links to patient outcomes.
The team collected data from multiple high-volume hospitals. They tracked treatment decisions for common cancers. Adherence rates varied widely. Centers that closely followed international guidelines often recorded better symptom control. Meanwhile, those relying mainly on national adaptations showed mixed results.
Higher adherence to evidence-based protocols reduced severe treatment side effects. Patients in high-adherence centers experienced fewer unplanned hospital stays. Survival rates improved modestly in groups with stronger guideline compliance. In contrast, lower adherence linked to delayed supportive care and higher toxicity rates.
The study highlighted clear differences. International guidelines frequently offered more detailed recommendations on newer therapies. National guidelines adapted better to local resource limits. However, incomplete adoption of either set created care gaps. Doctors sometimes modified protocols due to drug availability or cost pressures.
Investigators used statistical models to test associations. They controlled for patient age, cancer stage, and hospital resources. Results confirmed a positive connection between strict adherence and better clinical outcomes. Yet the strength of this link differed by cancer type. Breast and colorectal cases showed stronger benefits than some advanced solid tumors.
Experts note that consistent guideline use can raise care quality. Training programs and digital decision tools may boost adherence. Regular audits in tertiary centers can identify weak points. Further research should expand to more hospitals across different regions.
This analysis underscores the value of measuring real-world guideline use. It also shows how adherence levels influence patient recovery and safety in specialized cancer care settings.